Exciva Funding: $59M Raised, Series B (2026)

Exciva funding overview

Exciva is a Biotech company based in Heidelberg, Germany. Exciva has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Exciva runs through 2026; nothing later has been disclosed. Investors on record include Gimv, EQT Life Sciences, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.

Exciva at a glance

Total raised: $59M
Latest round: Series B
Latest round date: January 2026
Industry: Biotech
Headquarters: Heidelberg, Germany
Notable investors: Gimv, EQT Life Sciences, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures, Andera Partners, LBBW

Frequently asked about Exciva funding

How much has Exciva raised?: Exciva has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Exciva?: Gimv, EQT Life Sciences, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures are named among the investors backing Exciva.
What was the latest Exciva funding round?: The most recent disclosed round is a Series B, announced in January 2026.
Where is Exciva based?: Exciva is based in Heidelberg, Germany.
What sector does Exciva operate in?: Exciva is tracked under Biotech from Heidelberg, Germany, with $59M in disclosed funding.
When did Exciva last raise?: The last disclosed Exciva round closed in January 2026 at Series B.

Exciva totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Heidelberg below to benchmark round size and investor mix.

Exciva Funding: $59M Raised, Series B (2026)

Exciva funding overview

Exciva at a glance

Frequently asked about Exciva funding

Companies related to Exciva (33)

Browse related funding lists (6)